Real World Data on COVID-19 Vaccine Efficacy ‘Extremely Encouraging’
New Dosing Options And Populations Are Being Investigated
The effectiveness of coronavirus vaccines in preventing infection and symptomatic COVID-19 disease was explored at a virtual meeting held by the European Medicines Agency.
You may also be interested in...
Senior members of three key regulatory and health bodies this week gave their assessments of the protection that existing COVID-19 vaccines may offer against future strains of the virus, and the requirements for developing and assessing modified vaccines.
Coronavirus Notebook: EMA Probes Janssen Vaccine Blood Clot Reports, UK Advises 12-Week Dosing Gap For Moderna
The AZ vaccine is now under EU scrutiny over capillary leak syndrome, while Valneva has reported positive results with its product. The global COVAX initiative has delivered more than 38 million doses of vaccines to over a hundred countries.
The team behind Sputnik V has attacked what it calls “fake news and provocations” in the EU as political arguments over the vaccine claim another ministerial scalp.